Budget Incentives to Boost Indian Clinical Trial Market

The incentives offered by the government in union budget on research and development in FY 2011, is anticipated to boost the growth of the Indian clinical trial market, says RNCOS.

The R&D spending of drug companies could increase to the tune of 25-50% due to the incentives offered by the Indian government in its budget. This will propel the growth of Indian Clinical trial market.

Clinical Trials: A Methodologic Perspective Second Edition(Wiley Series in Probability and Statistics)

According to RNCOS research on the sector titled “Booming Clinical Trials Market in India”, the clinical trial outsourcing market in India is forecast to grow at a CAGR of around 31% during 2010-2012.